Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc is dated September 09, 2025. The document serves as a notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them, made in accordance with the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It is strictly a regulatory disclosure regarding insider trading activity.
Material Changes
The filing reports a specific transaction involving the sale of ordinary shares by a senior executive:
- Executive: Vasant Padmanabhan (President, Research & Development ENT)
- Transaction Type: Sale of ordinary shares
- Date: September 09, 2025
- Volume: 17,643 shares
- Price: £14.25 per share
- Location: Outside the trading venue
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risk factors, or details on contingencies and unusual items. The document is limited to the statutory notification of the share sale described above.
Investor Verification Checklist
- Verify the total number of shares held by Vasant Padmanabhan post-transaction to assess remaining ownership stakes.
- Confirm if this transaction was part of a pre-arranged trading plan (e.g., Rule 10b5-1 equivalent) by reviewing subsequent disclosures or company policy.
- Check the current market price of Smith & Nephew ordinary shares to compare against the £14.25 transaction price.
- Review the company's latest Form 20-F for comprehensive financial performance data, as this 6-K contains none.